Press Releases

SARASOTA, Fla., March 16, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: INVO) ("INVO"), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, today announced that its board of directors has approved a change in the Company's trading symbol from "IVOB" to "INVO." T

MINNEAPOLIS, March 16, 2020 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), the science-focused multi-state cannabis company with active operations in exclusively medical-only markets and licenses in 10 states and the commonwealth of Puerto Rico, today announced tha

WASHINGTON, March 16, 2020 /PRNewswire/ -- Today, the National Small Business Association (NSBA) is releasing a new poll on how the novel coronavirus (COVID-19) is impacting America's small businesses—sometimes to a devastating degree. This new poll quantifies the broad economic impact of COVID-19 and also includes many stories directly from small-business ow

REDWOOD CITY, Calif., March 16, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its fourth quarter and full year 2019 financial results."After only two quarters in 201

REDWOOD CITY, Calif., March 16, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced the execution of a definitive merger agreement to acquire Tetraphase Pharmaceuticals, Inc. (Tetrapha

PALO ALTO, Calif., March 16, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced its Halcyon™ 2.0 treatment system has been approved by the China National Medical Products Administration (NMPA), which allows the company to market this cancer treatment system in China. This system incorporates new imaging technologies

SAN FRANCISCO, March 16, 2020 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic non-alcoholic steatohepatitis (NASH) Company developing pioneering medicines designed to restore metabolic balance and improve overall health of NASH patients, today reported fourth quarter and full year financial results for the period ending

NASDAQ: CORV   TSX: CORVAcquisition Expected to Have a Total Purchase Price of Approximately US$76 Million Including the Repayment of Certain Correvio IndebtednessADVANZ PHARMA Intends to Pay for the Acquisition with Cash on HandProvides ADVANZ PHARMA with an Immediate and Direct Co

Transaction in connection with the previously announced transition plan NYSE | TSX : ACB  EDMONTON, March 16, 2020 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced that Te

Provides ADVANZ PHARMA with an immediate and direct commercial presence in Germany, France, Spain, Italy, and the Benelux region, while strengthening its existing presence in the Nordics and the United Kingdom Further diversifies ADVANZ PHARMA'